News
FedEx Express Named Asia’s Best Third-Party Logistics for Vaccine at the Asia Pacific Vaccine Excellence Awards 2021
FedEx Express (FedEx), a subsidiary of FedEx Corp. and one of the world’s largest express transportation companies, has been named “Asia’s Best 3PLs for Vaccines” at the Asia Pacific Vaccine Excellence Awards 2021 (AVEA 2021).
FedEx was selected as “Asia’s...
News
McSAF and Novasep announce their successful collaboration to produce a next-generation Antibody-Drug Conjugate
Novasep, a leading supplier of services and technologies for the life sciences industry, and McSAF, a French biotech based in Tours, specialized in bioconjugation tools to design innovative and efficient bio drugs for health and diagnostics, are pleased to...
Drug Research
Sanofi invests $180 million equity in Owkin’s artificial intelligence and federated learning to advance oncology pipeline
Sanofi announced an equity investment of $180 million and a new strategic collaboration with Owkin comprised of discovery and development programmes in four exclusive types of cancer, with a total payment of $90 million for three years plus additional...
News
New Zealand approves India-made vaccines, Covishield and Covaxin
New Zealand has finally approved India-made vaccines, Covishield and Covaxin. The decision comes soon after Australia, New Zealand’s neighbour, recognised the two Indian vaccines last month. This means that Indian travellers vaccinated with these vaccines will not have to...
News
GSK and Vir Biotechnology announce United States government agreements to purchase sotrovimab, a COVID-19 treatment
GlaxoSmithKline plc and Vir Biotechnology, Inc. announced US government contracts totalling approximately $1 billion (USD) to purchase sotrovimab, an investigational monoclonal antibody for the early treatment of COVID-19, which the US Food and Drug Administration (FDA) granted Emergency Use...
News
Pfizer to Provide U.S. Government with 10 Million Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat COVID-19
Pfizer Inc. announced an agreement with the U.S. government to supply 10 million treatment courses of its investigational COVID-19 oral antiviral candidate, PAXLOVID™ (PF-07321332; ritonavir), subject to regulatory authorization from the U.S. FDA. If approved or authorized, PAXLOVID, which...
Drug Research
uMotif collaborates with The University of Manchester on body mapping tool to accelerate pain reporting for people living with musculoskeletal conditions
uMotif, a leading eClinical platform provider powering patient-centric research, has joined up with researchers at The University of Manchester to investigate the real-world usability of its digital body mapping tool in a feasibility study in people living with musculoskeletal...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















